For anyone who purchased the affected nasal spray, the immediate priority is to prevent further exposure and follow the manufacturer's recall instructions.
Walgreens' statement, reported by TODAY.com and Fox Business, says customers with affected products should stop using them and return them to a Walgreens store for a full refund.
Step 1: Stop using the affected nasal spray
If your bottle matches either lot number, discontinue use immediately.
Do not continue using it simply because:
- The expiration date has not passed.
- The liquid looks clear.
- The bottle has no unusual smell.
- You have previously used the same product without experiencing problems.
Microbial contamination cannot reliably be identified through visual inspection.
Step 2: Keep the packaging for identification
Retain the bottle and its packaging until you have checked the recall instructions and arranged a return.
The lot number, product description and expiration date help establish whether the item falls within the recall.
Avoid transferring the remaining liquid into another container or sharing the product with another person.
Step 3: Return the product to Walgreens
The reported consumer remedy is a full refund.
Take the affected bottle to a Walgreens location and explain that it belongs to the recalled Walgreens Saline Nasal Spray with Xylitol batches.
If you no longer have the original packaging or receipt, ask the store's pharmacy or customer-service team how it handles the return.
Step 4: Contact a healthcare professional if you have health concerns
Anyone who used an affected bottle and is concerned about possible exposure should speak with a healthcare professional.
This is particularly relevant for people with weakened immune systems or existing respiratory conditions.
If you develop symptoms after using the product, explain the exposure and provide the product's lot information if available. A healthcare professional can determine whether further evaluation is appropriate.
The FDA also provides MedWatch for reporting suspected adverse events associated with regulated medical products. Its consumer recall guidance recommends following product-specific instructions and contacting healthcare professionals when illness or injury is suspected.
Step 5: Check official recall information
The FDA maintains drug enforcement records containing product descriptions, lot codes, recall classifications and current status.
Its general recall announcement page is not a complete database of every drug recall. Consequently, consumers should not assume that an item is safe simply because they cannot find it in a general news announcement or retailer recall listing.
Walgreens itself also describes its product recall page as noncomprehensive.
Expert Verdict: What the Recall Reveals About Nasal Spray Safety in 2026
The Walgreens incident raises an important question about consumer confidence in everyday over-the-counter healthcare products: how much attention should shoppers pay to manufacturing quality when a product appears relatively simple?
Saline nasal sprays are familiar household products. They are commonly used for nasal dryness, congestion and irritation, making them easy to overlook when considering medication safety.
But the recall illustrates why quality assurance matters even for products that do not contain conventional pharmaceutical ingredients intended to treat a specific disease.
1. A relatively low-risk classification does not eliminate the need for action
The Class II designation is meaningful because it indicates that the FDA considers serious adverse health consequences unlikely.
However, it does not mean that the recalled batches are suitable for continued use.
The manufacturer-specific instruction to discontinue use takes precedence for this product.
2. Contamination and illness are two different questions
There is a difference between identifying a microorganism in a product and establishing that consumers have become infected.
The FDA documented the presence of Pseudomonas lactis as the reason for the recall. The available enforcement record does not establish that all 41,328 bottles were contaminated or provide a confirmed count of resulting consumer infections.
USA Today's reporting also highlighted the limited scientific information about the organism's potential effects in this particular exposure scenario.
That distinction helps readers understand the recall without either exaggerating or dismissing the risk.
3. Manufacturing accountability extends beyond the retailer
The product carries the Walgreens brand, but Medical Products Laboratories initiated the recall.
This illustrates the complexity of modern retail healthcare products: a familiar pharmacy brand may depend on outside manufacturers, suppliers, testing facilities and distribution networks.
Consumers generally see the retailer's name on the bottle, not the entire manufacturing chain behind it.
The FDA's identification of the recalling firm provides an important layer of accountability and traceability.
4. The absence of a listing on a retailer's recall page can be misleading
Walgreens maintains a product recall information page, but its own disclaimer explains that the listing is not comprehensive.
The nasal spray recall does not appear in the page's currently displayed list of notices, even though the FDA enforcement record continues to identify it as ongoing.
This demonstrates why the FDA's drug enforcement database is especially important for checking the status of individual medication recalls.
5. The practical lesson is to check batches, not just brands
A recall does not necessarily make every product from a particular retailer unsafe.
The Walgreens incident involves one identified product, one bottle size and two affected lots.
For consumers, the most reliable approach is to match the product name, size, NDC and lot number against the official record before deciding whether a particular bottle is affected.
Professional assessment: The most significant takeaway is not simply that 41,328 bottles entered a recall process. It is that a routine consumer healthcare product can become a safety concern when microbial quality controls fail. Transparent manufacturing information, effective customer notification and accessible recall records are essential to restoring confidence.
Frequently Asked Questions (FAQ) About Walgreens Nasal Spray Recall
Q1: Which Walgreens nasal spray was recalled in 2026?
The recall involves Walgreens Saline Nasal Spray with Xylitol, sold in 1.5-ounce (45 mL) bottles. The FDA identified 41,328 bottles distributed nationwide. The affected product has NDC 0363-3114-01 and belongs to lot numbers 71409 and 71861.
Q2: What are the affected Walgreens nasal spray lot numbers and expiration dates?
The affected batches are:
- Lot 71409: Expires February 28, 2027.
- Lot 71861: Expires August 31, 2027.
Both belong to Walgreens Saline Nasal Spray with Xylitol. Check the lot number rather than relying on the expiration date alone.
Q3: Can I get a refund for recalled Walgreens nasal spray?
Yes. Walgreens told TODAY.com that customers with affected products should stop using them and return them to a Walgreens store for a full refund. Consumers should retain the packaging where possible and confirm return arrangements with the store.
Q4: Why was Walgreens nasal spray recalled?
The FDA identified microbial contamination involving Pseudomonas lactis in a non-sterile product. The contamination prompted a voluntary recall initiated by Medical Products Laboratories on November 12, 2025.
Q5: Is the Walgreens nasal spray recall a Class I or Class II recall?
It is a Class II recall. The FDA defines this category as a situation where exposure may cause temporary or medically reversible adverse health consequences, or where the probability of serious consequences is remote.
Q6: Does the recall affect every Walgreens nasal spray?
No. The documented recall specifically concerns Walgreens Saline Nasal Spray with Xylitol in 1.5-ounce bottles from two identified lots. It should not be confused with a recall of every Walgreens nasal-care product.
Q7: Is the Walgreens nasal spray recall still ongoing in November 2026?
The latest FDA enforcement database update available for this recall, dated October 28, 2026, lists its status as ongoing. Consumers should check the latest FDA enforcement information for any subsequent changes.
Conclusion: Final Verdict and What to Watch in 2026
The Walgreens nasal spray recall is a significant consumer-safety issue involving 41,328 bottles of Walgreens Saline Nasal Spray with Xylitol distributed across the United States.
The FDA identified Pseudomonas lactis contamination as the reason for the recall and classified the incident as Class II. The affected batches are lot 71409, expiring February 28, 2027, and lot 71861, expiring August 31, 2027.
Although the original recall began in November 2025, its FDA reference number, D-0179-2026, and ongoing status make it relevant to consumers researching the issue in 2026.
For households, the most important action is straightforward: check the product identification, stop using any matching bottle and return it to Walgreens for a refund.
For the broader healthcare industry, the incident reinforces the importance of manufacturing oversight, microbial quality controls and timely consumer communication.
The key question going forward is whether the recall process reaches all affected products and whether the FDA eventually records the action as terminated.
Until then, consumers should rely on the exact lot numbers and official regulatory information rather than generalized headlines or assumptions about the safety of every nasal spray sold under the Walgreens brand.
